Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. - Wikidata - awgldk - TriplyDB

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

http://www.wikidata.org/entity/Q36478653

about

Angiomotin Family Members: Oncogenes or Tumor Suppressors?Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2 Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.Angiomotin-like 2 interacts with and negatively regulates AKT.Novel linear motif filtering protocol reveals the role of the LC8 dynein light chain in the Hippo pathway.Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.Regulation of the Hippo Signaling Pathway by Ubiquitin Modification.The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.The physiological role of Motin family and its dysregulation in tumorigenesis.

P2860

Q33837277-B9A30BFC-0A92-4859-B052-3E0030F83D2C Q34535458-4364EDAC-BDA6-485B-9175-34372765DC01 Q37269215-354B2906-8CF7-4F6A-923D-D495134F87CB Q38403721-A03DCB93-FE3D-49BE-8A69-F9D43A4A6B04 Q39394211-F0E4AAFB-6A97-4C69-982F-C074FAA308A1 Q46151218-EA60E8D1-5AB2-45FC-99BB-20C721BEFEA4 Q47294135-C7F9E4B1-D092-4419-91F5-21FBE64CB653 Q47354887-43CA66E6-355C-45A6-928E-6859412FD870 Q49797883-40CA75A7-0BFB-438C-91EB-F66C6509AE23 Q49957696-BC353FDC-B6DE-4848-8F49-D41C893CE44F Q50883426-8A220F36-F0DB-4ED3-9C0E-46906E7A1DE9 Q52591394-76B892F6-28BF-40F6-B805-923555D4E2C2

P2860

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

http://www.wikidata.org/entity/Q36478653

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@ast

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@en

type

label

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@ast

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@en

prefLabel

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@ast

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

@en

P1433

Q36478653-A0EE078E-15FC-4A8F-B18D-7B3C11681E5C

P1476

Q36478653-00866A1F-EAF6-4191-9DEA-AEDD47D22E66

P2093

Q36478653-5654C2DE-2666-4E0E-B7B4-BFF41E8006DB

Q36478653-65E223EE-6095-4CA9-AF4A-8855C54ED8A1

Q36478653-8F32002A-B53F-4F27-B44C-764B00721808

Q36478653-F8532119-9B71-47AA-B055-C6B5FBFF5150

P2860

Q36478653-0374EDCA-0275-4945-8EA6-7724B5265607

Q36478653-065C644D-ADFD-40ED-A6A2-89148CF84C31

Q36478653-0C0493AD-40E5-46D3-9804-28E6C6C130C1

Q36478653-12BF3C29-033A-4411-9082-51266DDB1B3B

Q36478653-13663C56-C32D-476C-842E-77B5ADC8A9DC

Q36478653-187C2E5D-D154-44F9-89C3-092B8551AFF6

Q36478653-19E22051-6564-45A1-8142-EE7922AE772D

Q36478653-2049BA6A-912F-49DF-9140-DD5DCE55BF5D

Q36478653-2CEA3329-EAA7-4F78-A961-7067534A9E0E

Q36478653-3025467F-F79C-4A5E-9EB0-0058B9EEE203

P304

Q36478653-35B7F3F7-CCAC-4D9C-9CF7-14948162DB94

P31

Q36478653-A2C88009-C93A-476A-956B-EB98DA09F842

P356

Q36478653-26A0786F-D6FA-44A0-BFE6-E3CF151F4560

P433

Q36478653-C6C1DB5B-FB1F-4399-A618-FE45D4DF1496

P478

Q36478653-3DCE0B32-9466-4CFD-829C-2CCAB391DC04

P50

Q36478653-8DD347F1-9946-4DB3-BC3F-6B0252C56B5C

P577

Q36478653-9574C7EA-CD6F-4710-B8E1-49A18C4E8614

P698

Q36478653-D11D6AF7-14D9-4674-9BA1-233C1932C57E

P921

Q36478653-463CDF87-EE90-4473-BB58-46E851182655

P932

Q36478653-8BCF61FC-5B7B-4129-909A-8EA510DEA470

P356

P1433

P1476

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition

@en

P2093

Cheolju Lee

http://www.w3.org/2001/XMLSchema#string

Miju Kim

http://www.w3.org/2001/XMLSchema#string

Minchul Kim

http://www.w3.org/2001/XMLSchema#string

Seong-Jun Park

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination

Angiomotin-like proteins associate with and negatively regulate YAP1

Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2

P304

64-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMBR.201540809

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26598551

http://www.w3.org/2001/XMLSchema#string

P921

protein ubiquitination

P932

4718409

http://www.w3.org/2001/XMLSchema#string